Highlights

  •  The fight against cancer is becoming more robust with the development of better treatments as time passes.
  • India showed a new direction in the fight against cancer with a story of a person who used self-reliance as a mantra to beat the disease.
  • “The person was cured using the indigenous treatment method called CAR-T cell therapy.”

Cancer, a disease synonymous with death, has witnessed several victories as better treatments have emerged over time. In India, a new direction in the fight against cancer has been showcased through the story of a patient who successfully beat cancer through a self-reliant approach. The patient, a Delhi resident gastroenterologist named Dr. VK Gupta, was cured by an indigenous treatment method called CAR-T cell therapy, which genetically engineers the patient’s T cells to attack cancer cells. CAR T-cell therapy is a type of cancer immunotherapy treatment that involves genetically altering an individual’s T cells in a laboratory. T cells refers to a type of immune system cell, or white blood cell, which can be used to fight cancer.

Read More News: Cancer Detection: Introducing Blood-Based Screening

Recently, the Central Drugs Standard Control Organization (CDSCO) approved the commercial use of this method, and it cost Dr. Gupta 42 lakh rupees, which is only one-tenth of what it would have cost abroad (4 crore). CAR-T cell therapy is a type of immunotherapy that involves extracting T cells from the patient’s body and combining them with a special protein in the laboratory to create Car-T. The transformed T cells, when reintroduced into the patient’s body, recognize cancer cells and start attacking them.

Read More News: 75% of cancers spread because of one protein, and we may be able to stop it

The central agency allowed the commercial use of this treatment in October last year. After that, the therapy successfully helped a patient fight against cancer. Presently, this treatment is available in 30 hospitals in 10 cities of India for patients above fifteen years of age who are suffering from B-cell cancer.

Source Link

By Editor

Leave a Reply